Infections complicating cesarean delivery

Current Opinion in Infectious Diseases

Volumn 31, Issue 4, 2018, Pages 368-376

  Sood, Geeta ^a   Argani, Cynthia ^a   Ghanem, Khalil G ^a   Perl, Trish M ^b   Sheffield, Jeanne S ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cesarean section infections; cesarean section infections; pregnancy; prophylaxis; sepsis

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN;

ANTIBIOTIC PROPHYLAXIS; CESAREAN SECTION; DISEASE SURVEILLANCE; HEALTH CARE QUALITY; HUMAN; INFECTION PREVENTION; NONHUMAN; OBESITY; PATHOGENESIS; REVIEW; SURGICAL INFECTION; TREATMENT DURATION; VACUUM ASSISTED CLOSURE; WOUND CLOSURE; DISEASE MANAGEMENT; FEMALE; HEALTH CARE PLANNING; HEALTH SURVEY; PREGNANCY; RISK FACTOR; WOUND HEALING;

ANTIBIOTIC PROPHYLAXIS; CESAREAN SECTION; DISEASE MANAGEMENT; FEMALE; HEALTH RESOURCES; HUMANS; PREGNANCY; PUBLIC HEALTH SURVEILLANCE; RISK FACTORS; STANDARD OF CARE; SURGICAL WOUND INFECTION; WOUND CLOSURE TECHNIQUES; WOUND HEALING;

EID: 85049850127     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000472     Document Type: Review

References (83)

1. Martin JA, Hamilton BE, Osterman MJ, et al. Births: Final Data for 2015. National vital statistics reports: From the Centers for Disease Control and Prevention, National Center for Health Statistics. Natl Vital Stat Rep 2017; 66:1-65.
2. Betran AP, Ye J, Moller AB, et al. The increasing trend in caesarean section rates: Global, regional and national estimates: 1990-2014. PLoS One 2016; 11:e0148343.
3. Hammad IA, Chauhan SP, Magann EF, Abuhamad AZ. Peripartum complications with cesarean delivery: A review of Maternal-Fetal Medicine Units Network publications. J Matern Fetal Neonatal Med 2014; 27:463-474.
4. Moroz LA, Wright JD, Ananth CV, Friedman AM. Hospital variation in maternal complications following caesarean delivery in the United States: 2006-2012. BJOG 2016; 123:1115-1120.
5. Uribe-Leitz T, Jaramillo J, Maurer L, et al. Variability in mortality following caesarean delivery, appendectomy, and groin hernia repair in low-income and middle-income countries: A systematic review and analysis of published data. Lancet Glob Health 2016; 4:e165-e174.
6. Ye J, Zhang J, Mikolajczyk R, et al. Association between rates of caesarean section and maternal and neonatal mortality in the 21st century: A worldwide populationbased ecological study with longitudinal data. BJOG 2016; 123:745-753.
7. Gelaw KA, Aweke AM, Astawesegn FH, et al. Surgical site infection and its associated factors following cesarean section: A cross sectional study from a public hospital in Ethiopia. Patient Saf Surg 2017; 11:18.
8. Ferraro F, Piselli P, Pittalis S, et al. Surgical site infection after caesarean section: Space for postdischarge surveillance improvements and reliable comparisons. New Microbiol 2016; 39:134-138.
9. De Nardo P, Gentilotti E, Nguhuni B, et al. Postcaesarean section surgical site infections at a Tanzanian tertiary hospital: A prospective observational study. J Hosp Infect 2016; 93:355-359.
10. Yang XJ, Sun SS. Comparison of maternal and fetal complications in elective and emergency cesarean section: A systematic review and meta-analysis. Arch Gynecol Obstet 2017; 296:503-512.
11. Buchmann EJ, StonesW, Thomas N. Preventing deaths from complications of labour and delivery. Best Pract Res Clin Obstet Gynaecol 2016; 36:103-115.
12. Brisibe SF, Ordinioha B, Gbeneolol PK. The effect of hospital infection control policy on the prevalence of surgical site infection in a tertiary hospital in South-South Nigeria. Niger Med J 2015; 56:194-198.
13. Chu K, Maine R, Trelles M. Cesarean section surgical site infections in sub-Saharan Africa: A multicountry study from Medecins Sans Frontieres. World J Surg 2015; 39:350-355.
14. Fawsitt CG, Meaney S, Greene RA, Corcoran P. Surgical site infection after caesarean section?. There is an app for that: Results from a feasibility study on costs and benefits. Ir Med J 2017; 110:635.
15. Castillo E, McIsaac C, MacDougall B, et al. Post-caesarean section surgical site infection surveillance using an online database and mobile phone technology. J Obstet Gynaecol Can 2017; 39:645.e1-651.e1.
16. Halwani MA, Turnbull AE, Harris M, et al. Postdischarge surveillance for infection following cesarean section: A prospective cohort study comparing methodologies. Am J Infect Control 2015; 44:455-447.
17. Shree R, Park SY, Beigi RH, et al. Surgical site infection following cesarean delivery: Patient, provider, and procedure-specific risk factors. Am J Perinatol 2016; 33:157-164.
18. Moulton LJ, Munoz JL, Lachiewicz M, et al. Surgical site infection after cesarean delivery: Incidence and risk factors at a US academic institution. J Matern Fetal Neonatal Med 2017; 1-8.
19. Vallejo MC, Attaallah AF, Shapiro RE, et al. Independent risk factors for surgical site infection after cesarean delivery in a rural tertiary care medical center. J Anesth 2017; 31:120-126.
20. Boggess KA, Tita A, Jauk V, et al. Risk factors for postcesarean maternal infection in a trial of extended-spectrum antibiotic prophylaxis. Obstet Gynecol 2017; 129:481-485.
21. Wodajo S, Belayneh M, Gebremedhin S. Magnitude and factors associated with post-cesarean surgical site infection at Hawassa University Teaching and Referral Hospital, Southern Ethiopia: A cross-sectional study. Ethiop J Health Sci 2017; 27:283-290.
22. Farret TC, Dalle J, Monteiro Vda S, et al. Risk factors for surgical site infection following cesarean section in a Brazilian Women's Hospital: A case-control study. Braz J Infect Dis 2015; 19:113-117.
23. Smid MC, Kearney MS, Stamilio DM. Extreme obesity and postcesarean wound complications in the maternal-fetal medicine unit cesarean registry. Am J Perinatol 2015; 32:1336-1341.
24. Smid MC, Dotters-Katz SK, Grace M, et al. Prophylactic negative pressure wound therapy for obese women after cesarean delivery: A systematic review and meta-analysis. Obstet Gynecol 2017; 130:969-978.
25. Yamasato K, Yoshino K, Chang AL, et al. Cesarean delivery complications in womenwithmorbid obesity. J Matern FetalNeonatalMed 2016; 29:3885-3888.
26. McKibben RA, Pitts SI, Suarez-Cuervo C, et al. Practices to Reduce surgical site infections among women undergoing cesarean section: A review. Infect Control Hosp Epidemiol 2015; 36:915-921.
27. Kunkle CM, Marchan J, Safadi S, et al. Chlorhexidine gluconate versus povidone iodine at cesarean delivery: A randomized controlled trial. J Matern Fetal Neonatal Med 2015; 28:573-577.
28. Springel EH, Wang XY, Sarfoh VM, et al. A randomized open-label controlled trial of chlorhexidine-alcohol vs povidone-iodine for cesarean antisepsis: The CAPICA trial. Am J Obstet Gynecol 2017; 217:463.e1-463.e8.
29. Ngai IM, Van Arsdale A, Govindappagari S, et al. Skin preparation for prevention of surgical site infection after cesarean delivery: A randomized controlled trial. Obstet Gynecol 2015; 126:1251-1257.
30. Tuuli MG, Liu J, Stout MJ, et al. A randomized trial comparing skin antiseptic agents at cesarean delivery. N Engl J Med 2016; 374:647-655.
31. Huang H, Li G, Wang H, He M. Optimal skin antiseptic agents for prevention of surgical site infection in cesarean section: A meta-analysis with trial sequential analysis. J Matern Fetal Neonatal Med 2017; 1-8.
32. Hinkson L, Siedentopf JP, Weichert A, Henrich W. Surgical site infection in cesarean sections with the use of a plastic sheath wound retractor compared to the traditional self-retaining metal retractor. Eur J Obstet Gynecol Reprod Biol 2016; 203:232-238.
33. Scolari Childress KM, Gavard JA, Ward DG, et al. A barrier retractor to reduce surgical site infections and wound disruptions in obese patients undergoing cesarean delivery: A randomized controlled trial. Am J Obstet Gynecol 2016; 214:285; e1- e10.
34. Shrem G, Egozi T, Naeh A, et al. Precesarean Staphylococcus aureus nasal screening and decolonization: A prospective randomized controlled trial. J Matern Fetal Neonatal Med 2016; 1-25.
35. Caissutti C, Saccone G, Zullo F, et al. Vaginal cleansing before cesarean delivery: A systematic review and meta-analysis. Obstet Gynecol 2017; 130:527-538.
36. Haas DM, Morgan S, Contreras K. Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections. Cochrane Database Syst Rev 2014; (9):CD007892.
37. Zaki MN, Truong M, Pyra M, et al. Wound complications in obese women after cesarean: A comparison of staples versus subcuticular suture. J Perinatol 2016; 36:819-822.
38. Wang H, Hong S, Teng H, et al. Subcuticular sutures versus staples for skin closure after cesarean delivery: A meta-analysis. J Matern Fetal Neonatal Med 2016; 29:3705-3711.
39. Mackeen AD, Schuster M, Berghella V. Suture versus staples for skin closure after cesarean: A metaanalysis. Am J Obstet Gynecol 2015; 212:621.e1-621.10.
40. Daykan Y, Sharon-Weiner M, Pasternak Y, et al. Skin closure at cesarean delivery, glue vs subcuticular sutures: A randomized controlled trial. Am J Obstet Gynecol 2017; 216:406.e1-406.e5.
41. Buresch AM, Van Arsdale A, Ferzli M, et al. Comparison of subcuticular suture type for skin closure after cesarean delivery: A randomized controlled trial. Obstet Gynecol 2017; 130:521-526.
42. Tuuli MG, Stout MJ, Martin S, et al. Comparison of suture materials for subcuticular skin closure at cesarean delivery. Am J Obstet Gynecol 2016; 215:490.e1-490.5.
43. Hasdemir PS, Guvenal T, Ozcakir HT, et al. Comparison of subcuticular suture materials in cesarean skin closure. Surg Res Pract 2015; 2015:141203.
44. Schrufer-Poland TL, Ruiz MP, Kassar S, et al. Incidence of wound complications in cesarean deliveries following closure with absorbable subcuticular staples versus conventional skin closure techniques. Eur J Obstet Gynecol Reprod Biol 2016; 206:53-56.
45. Pergialiotis V, Prodromidou A, Perrea DN, Doumouchtsis SK. The impact of subcutaneous tissue suturing at caesarean section on wound complications: A meta-analysis. BJOG 2017; 124:1018-1025.
46. Walton RB, Shnaekel KL, Ounpraseuth ST, et al. High transverse skin incisions may reduce wound complications in obese women having cesarean sections: A pilot study. J Matern Fetal Neonatal Med 2017; 1-5.
47. Peleg D, Eberstark E, Warsof SL, et al. Early wound dressing removal after scheduled cesarean delivery: A randomized controlled trial. Am J Obstet Gynecol 2016; 215:388.e1-388.5.
48. Stanirowski PJ, Bizon M, Cendrowski K, Sawicki W. Randomized controlled trial evaluating dialkylcarbamoyl chloride impregnated dressings for the prevention of surgical site infections in adult women undergoing cesarean section. Surg Infect (Larchmt) 2016; 17:427-435.
49. Looby MA, Vogel RI, Bangdiwala A, et al. Prophylactic negative pressure wound therapy in obese patients following cesarean delivery. Surg Innov 2018; 25:43-49.
50. Strugala V, Martin R. Meta-analysis of comparative trials evaluating a prophylactic single-use negative pressure wound therapy system for the prevention of surgical site complications. Surg Infect (Larchmt) 2017; 18:810-819.
51. Liu Z, Dumville JC, Norman G, et al. Intraoperative interventions for preventing surgical site infection: An overview of Cochrane Reviews. Cochrane Database Syst Rev 2018; (2):CD012653.
52. Bollig C, Nothacker M, Lehane C, et al. Prophylactic antibiotics before cord clamping in cesarean delivery: A systematic review. Acta Obstet Gynecol Scand 2018; 97:521-535.
53. American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 120: Use of prophylactic antibiotics in labor and delivery. Obstet Gynecol 2011; 117:1472-1483.
54. Bailey SR, Field N, Townsend CL, et al. Antibiotic prophylaxis for women undergoing caesarean section and infant health. BJOG 2016; 123:875-876.
55. Seedat F, Stinton C, Patterson J, et al. Adverse events in women and children who have received intrapartum antibiotic prophylaxis treatment: A systematic review. BMC Pregnancy Childbirth 2017; 17:247.
56. Zachariassen G, Hyldig N, Joergensen JS, et al. The half-life and exposure of cefuroxime varied in newborn infants after a Caesarean section. Acta Paediatr 2016; 105:1074-1078.
57. Dlamini LD, Sekikubo M, Tumukunde J, et al. Antibiotic prophylaxis for caesarean section at a Ugandan hospital: A randomised clinical trial evaluating the effect of administration time on the incidence of postoperative infections. BMC Pregnancy Childbirth 2015; 15:91.
58. Ben Shoham A, Bar-Meir M, Ioscovich A, et al. Timing of antibiotic prophylaxis in cesarean section: Retrospective, difference-in-differences estimation of the effect on surgical-site-infection. J Matern Fetal Neonatal Med 2017; 1-5.
59. Zhang C, Zhang L, Liu X, et al. Timing of antibiotic prophylaxis in elective caesarean delivery: A multi-center randomized controlled trial and metaanalysis. PLoS One 2015; 10:e0129434.
60. Groff SM, Fallatah W, Yang S, et al. Effect of maternal obesity on maternalfetal transfer of preoperative cefazolin at cesarean section. J Pediatr Pharmacol Ther 2017; 22:227-232.
61. Young OM, Shaik IH, Twedt R, et al. Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery. Am J Obstet Gynecol 2015; 213:541e1-e5417.
62. Maggio L, Nicolau DP, DaCosta M, et al. Cefazolin prophylaxis in obese women undergoing cesarean delivery: A randomized controlled trial. Obstet Gynecol 2015; 125:1205-1210.
63. Swank ML, Wing DA, Nicolau DP, McNulty JA. Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women. Am J Obstet Gynecol 2015; 213:415e1-e4158.
64. Westen EH, Kolk PR, van Velzen CL, et al. Single-dose compared with multiple day antibiotic prophylaxis for cesarean section in low-resource settings, a randomized controlled, noninferiority trial. Acta Obstet Gynecol Scand 2015; 94:43-49.
65. Valent AM, DeArmond C, Houston JM, et al. Effect of post-cesarean delivery oral cephalexin and metronidazole on surgical site infection among obese women: A randomized clinical trial. JAMA 2017; 318:1026-1034.
66. Pinto-Lopes R, Sousa-Pinto B, Azevedo LF. Single dose versus multiple dose of antibiotic prophylaxis in caesarean section: A systematic review and metaanalysis. BJOG 2017; 124:595-605.
67. Stinson LF, Payne MS, Keelan JA. Planting the seed: Origins, composition, and postnatal health significance of the fetal gastrointestinal microbiota. Crit Rev Microbiol 2017; 43:352-369.
68. Kikhney J, von Schoning D, Steding I, et al. Is Ureaplasma spp. the leading causative agent of acute chorioamnionitis in women with preterm birth?. Clin Microbiol Infect 2017; 23:119; e1- e7.
69. Ward E, Duff P. A comparison of 3 antibiotic regimens for prevention of postcesarean endometritis: An historical cohort study. Am J Obstet Gynecol 2016; 214:751.e1-751.4.
70. Tita AT, Szychowski JM, Boggess K, et al. Adjunctive azithromycin prophylaxis for cesarean delivery. N Engl J Med 2016; 375:1231-1241.
71. Harper LM, Kilgore M, Szychowski JM, et al. Economic evaluation of adjunctive azithromycin prophylaxis for cesarean delivery. Obstet Gynecol 2017; 130:328-334.
72. Skeith AE, Niu B, Valent AM, et al. Adding azithromycin to cephalosporin for cesarean delivery infection prophylaxis: A cost-effectiveness analysis. Obstet Gynecol 2017; 130:1279-1284.
73. Sutton AL, Acosta EP, Larson KB, et al. Perinatal pharmacokinetics of azithromycin for cesarean prophylaxis. Am J Obstet Gynecol 2015; 212:812.e1-812.e6.
74. Weinstein RA, Boyer KM. Antibiotic prophylaxis for cesarean delivery - when broader is better. N Engl J Med 2016; 375:1284-1286.
75. Carter EB, Temming LA, Fowler S, et al. Evidence-based bundles and cesarean delivery surgical site infections: A systematic review and metaanalysis. Obstet Gynecol 2017; 130:735-746.
76. Temming LA, Raghuraman N, Carter EB, et al. Impact of evidence-based interventions on wound complications after cesarean delivery. Am J Obstet Gynecol 2017; 217:449; e1- e9.
77. Hsu CD, Cohn I, Caban R. Reduction and sustainability of cesarean section surgical site infection: An evidence-based, innovative, and multidisciplinary quality improvement intervention bundle program. Am J Infect Control 2016; 44:1315-1320.
78. Hickson E, Harris J, Brett D. A journey to zero: Reduction of postoperative cesarean surgical site infections over a five-year period. Surg Infect (Larchmt) 2015; 16:174-177.
79. Stokholm J, Thorsen J, Chawes BL, et al. Cesarean section changes neonatal gut colonization. J Allergy Clin Immunol 2016; 138:881-889; e2.
80. Rutayisire E, Huang K, Liu Y, Tao F. The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants' life: A systematic review. BMC Gastroenterol 2016; 16:86.
81. Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: Implications for health outcomes. Nat Med 2016; 22:713-722.
82. van Best N, Hornef MW, Savelkoul PH, Penders J. On the origin of species: Factors shaping the establishment of infant's gut microbiota. Birth defects research Part C. Embryo Today: Reviews 2015; 105:240-251.
83. Romano-Keeler J, Weitkamp JH. Maternal influences on fetal microbial colonization and immune development. Pediatr Res 2015; 77(1-2): 189-195.